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Abstract:
Raman spectra of oxygenated intermediates of Nanodisc incorporated
human CYP17 in the presence of natural substrates directly confirm that
substrate structure effectively alters H-bonding interactions with the critical
Fe-O-O fragment so as to dictate its predisposition for one of two alternative
reaction pathways, providing a realistic structural explanation for substrate
control of CYP17 reactivity that has profound physiological implications.
Keywords: biophysics, heme proteins, oxidoreductases, Raman
spectroscopy, lyase reaction.

CYP17A1 is a member of the cytochrome P450 superfamily that
occupies a central role in the biosynthesis of steroid hormones.[1,2] This
enzyme catalyzes both the hydroxylation of its primary substrates
pregnenolone and progesterone as well as the subsequent 17,20
carbon-carbon lyase chemistry which is the first committed step in the
biosynthesis of androgens.[1–3] There is significant debate as to the
chemical mechanisms of this lyase activity, with human CYP17
exhibiting a significant preference for 17-hydroxy pregnenolone over
17-hydroxy progesterone. In vivo, the predominant pathway forming
androgens proceeds through the conversion of hydroxypregnenolone
to dehydroepiandrosterone.[4–6] We report newly acquired resonance
Raman (rR) spectra of monomeric CYP17A1 self-assembled in
Nanodiscs, which reveal a distinct difference in hydrogen bonding to
the ferrous dioxygen intermediate. With 17-hydroxyprogesterone, the
oxygen vibrational modes indicate hydrogen bonding to the distal
oxygen of the Fe-O-O fragment, whereas with 17hydroxypregnenolone hydrogen bonding is to the proximal oxygen. To
the extent that such interactions persist in the subsequent peroxointermediate, the latter interaction is expected to inhibit O-O bond
cleavage relative to the former, permitting nucleophilic attack of the
peroxo intermediate on the 20-carbonyl. This observation of
differential H-bonding interactions, alone, satisfactorily explains the
dramatically lower activity of the Δ-4 progesterone substrate relative
to that of the Δ-5 pregnenolone compound in androgen biosynthesis.
These results constitute a definitive experimental confirmation of the
role of substrate structure in directly controlling the metabolic

Angewandte Chemie International Edition, Vol. 52, No. 20 (May 2013): pg. 5342-5345. DOI. This article is © Wiley-VCH
Verlag and permission has been granted for this version to appear in e-Publications@Marquette. Wiley-VCH Verlag does
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission
from Wiley-VCH Verlag.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

processing of these dual function cytochrome P450s and support the
role of the peroxoanion in maintaining high lyase activity.
The cytochromes P450 (CYPs) are heme-containing
monooxygenases that participate in a wide range of physiologically
important processes in both eukaryotic and prokaryotic organisms.[7]
In vertebrates, one essential function of CYPs is the transformation of
cholesterol into steroid hormones through the involvement of highly
stereo- and regio-specific reactions ultimately yielding the corticoids,
androgens, and estrogens.[1–3] These steroidogenic P450s act on a
select number of compounds, some catalyzing only hydroxylation
chemistry, with others also active in carbon-carbon bond cleavage.
The chemical intermediates responsible for this variable reactivity have
been the subject of much debate, yielding questions as to how these
enzymes control multi-state oxidative transformations.[8,9]
The membrane bound CYP17 lies at the heart of steroid
metabolism where it carries out standard monooxygenase chemistry,
converting pregnenolone (PREG) and progesterone (PROG), to 17α-OH
pregnenolone (OH-PREG) and 17α-OH progesterone (OH-PROG),
respectively, apparently utilizing a “Compound I” to initiate hydrogen
abstraction and radical recombination in the classic “Groves rebound”
mechanism.[7–10] However, these hydroxylated products can also serve
as substrates in a second oxidative cycle to cut the 17–20 carboncarbon bond to form dehydroepiandrosterone and androstenedione
(Figure 1).[1,2] This reaction represents a critical branch point in human
steroidogenesis at which the hydroxylated products of CYP17 are
either shunted towards production of corticoids or subjected to a
second round of catalysis that constitutes the first committed step of
androgen formation.
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Figure 1

The proposed pathway for biosynthesis of androstenedione and

dehydroepiandrosterone catalyzed by human CYP17A1. The full enzymatic cycle is
shown in Supporting Information, Figure S1.

Clearly, elucidating the factors that control CYP17 product
formation is crucial for understanding healthy and diseased human
physiology. Particularly intense scrutiny of the C-C lyase activity of this
enzyme has led to suggestions that nucleophilic attack on the C-20
carbonyl by the early peroxo-ferric intermediate is utilized in the
formation of androgens.[11–13] This led us to seek structural features of
the active site that could control a branch point between O-O bond
scission/Compound I formation versus a heme-oxygen intermediate
reactive in C-C lyase chemistry. Since androgen formation is 50-fold
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greater with OH-PREG than for OH-PROG, this substrate pair was used
for our investigations.[4,6,14,15]
An important step towards the understanding of androgen
formation was the recently reported crystal structure by DeVore and
Scott of human CYP17A1 in complex with promising anti-cancer
drugs.[16] These authors used molecular modeling to suggest that
interactions of the 3β-alcohol or corresponding ketone fragments of
PREG and PROG with active site H-bonding residues place the
substrate in correct orientation with respect to the heme prosthetic
group, also making the point that the active site topology might be
altered by substrates and stressed the pressing need for further
experimental work.[16]
The Nanodisc system allows functional incorporation of these
membrane proteins into homogenous and monodisperse membrane
environments to yield exceptionally well-behaved ligand binding
properties, showing clean conversions of spin-state populations, and
also enhances stability of their dioxygen adducts.[17–20] Combination of
this system with the power of rR spectroscopy to interrogate active
site structure in heme proteins presents an especially effective
approach to explore the complex mechanism of CYP17A1. Specifically
addressed in this report is a particularly intriguing aspect of CYP17A1
structure, wherein the choice of substrate controls hydrogen bonding
that defines the catalytic channel for product formation.[4–6,15] Herein
rR spectroscopy convincingly demonstrates that the single difference
at the 3β position of OH-PREG and OH-PROG leads to unequivocal
changes in active site H-bonding interactions with the key Fe-O-O
fragment of enzymatic intermediates, leading to alterations in
electronic structure that then control substrate processing.
Shown in Figure 2A are the rR spectra obtained for the 16O2
adduct of PROG-bound CYP17. In addition to structure-sensitive heme
modes, including ν4, ν3, and ν2, the key ν(16O-16O) mode is observed
at 1140 cm−1, as confirmed by the uncluttered 16O2/18O2 difference
spectrum. The ν(Fe-O) stretching mode appears at 536 cm−1, as
documented in the 16O2/18O2 difference trace (Figure 2A). These
frequencies for the Fe-O-O fragment are quite similar to those
observed when this fragment is weakly H-bonded to P450 active site
residues.[21,22] Significantly, spectra acquired for this sample in
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solutions prepared in D2O (left and right traces in lower section of
Figure 2A) showed no difference for this non-H-bonding substrate.

Figure 2

The rR spectra of PROG and 17-OH-PROG bound

16O
2

adducts of

ND:CYP17 in H2O buffer (panel A and B, respectively). The lower section of each panel
shows 16O2-18O2 difference plots in H2O (upper) and D2O (lower) buffers.

Shown in Figure 2B, top trace, is the rR spectrum obtained for
the 16O2 adduct of CYP17 harboring OH-PROG at its active site. The
ν(16O-16O) mode now appears ~9 cm−1 lower at 1131 cm−1. Expansion
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of this spectral region, and comparison with the spectrum acquired
with 18O2, shows evidence for a minor conformer that is apparently
quite similar to the form observed when PROG is bound (Figure 2A).
As is evidenced by a telltale 2 cm−1 shift to higher frequency in
solutions prepared in D2O,[21] the dominant form, occurring at 1131
cm−1, is H-bonded (Figure 2B, lower right). It is most reasonable to
attribute the clearly observed H-bonding interaction to the newly
introduced C17-OH(D) functionality; note that this lowering of the ν(OO) mode is correlated with a corresponding 6 cm−1 increase in the
frequency of the ν(Fe-O) band relative to its value in the PROG-bound
enzyme.
Corresponding spectral data for the PREG and 17-OH-PREGbound enzymes are shown in Figure 3. As for the PROG-bound
enzyme, the ν(O-O) and ν(Fe-O) modes of the PREG-bound enzyme
are observed near 1140 and 535 cm−1 with no evidence for H-bonding.
As shown in Figure 3B, for the OH-PREG sample, the ν(O-O) mode is
shifted down by only 5 cm−1 compared with its value for the PREGbound form and exhibits a barely detectable upshift in deuterated
solvents. Now however, the ν(Fe-O) is observed at 526 cm−1,
exhibiting a 9 cm−1 shift to lower frequency compared to the value
observed for the sample containing non-H-bonding PREG. The main
point is that rather dramatic differences are observed when comparing
the samples bound with OH-PROG and OH-PREG. Though introduction
of the 17-OH group causes downshifts of the ν(O-O) modes for both
OH-PROG and OH-PREG, the corresponding ν(Fe-O) modes shift in
opposite directions; i.e., the 17-OH-PROG yields a 6 cm−1 upshift while
the 17-OH-PREG shows a 9 cm−1 downshift. It is emphasized that rR
spectra acquired with 356 nm excitation for all four samples showed
no evidence for changes in the trans Fe-S bond strength (data not
shown), indicating that the effects on the Fe-O-O fragment arise
mainly from distal side interactions.
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Figure 3

The rR spectra of PREG and 17-OH-PREG bound

16O
2

adducts of

ND:CYP17 in H2O buffer (panel A and B respectively). The lower section of each panel
shows 16O2-18O2 difference plots in H2O (upper) and D2O (lower) buffers.

While reference data for the vibrational modes of dioxygen
adducts of heme proteins are relatively scarce certain fundamental
patterns have emerged.[21–26] Studies of globin mutants indicate that
H-bonds to the inner (proximal) O of the Fe-O-O fragment cause a
decrease in the ν(Fe-O) mode, with similar but smaller effects on the
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ν(O-O); i.e., a positive correlation,[23] whereas H-bonding to the outer
(terminal) O often leads to significant lowering of the ν(O-O) fragment
in P450s and related enzymes.[21,24–26] Importantly, recent DFT
calculations on histidine-ligated oxy complexes predict that,[22] other
factors being held constant, H-bond donation to the proximal oxygen
atom (OP) will weaken both bonds by withdrawing of electrons into the
non-bonding sp2 orbital on the OP, causing both the ν(Fe-O) and the
ν(O-O) modes to shift in concert to lower frequency. In contrast, Hbond donation to the terminal oxygen, OT, results in a straightforward
increase in back-bonding; i.e., one expects a negative correlation,
where the ν(O-O) decreases while the ν(Fe-O) increases. Therefore,
collectively, these rR results provide convincing evidence that the two
hydroxylated substrates interact at opposite ends of the Fe-O-O
fragment, as depicted in Figure 4, leading to crucial implications for
CYP17A1 function; i.e., it is anticipated that these interactions will
dictate the preference for the hydroxylation and lyase pathways. Such
H-bonding interactions with OT are expected to promote O-O bond
cleavage and Compound I formation, whereas the H---OP interaction
should prolong the lifetime of the ferric peroxo- intermediate that is
suggested to be the active fragment in the lyase reaction.[27,28] Indeed,
such differences in OT vs OP H-bonding interactions have been invoked
for the nitric oxide synthase reaction; in the first cycle the arginine
substrate is suggested to provide a H---OT interaction and facilitate
Compound I formation, whereas in the second cycle the hydroxylated
substrate (NOHA) is believed to provide a H---OP interaction and
proceed through a peroxo-intermediate.[26,29,30]
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Figure 4

Graphical representation of human CYP17A1 protein substrate interaction

derived from these newly acquired rR data.

In summary, rR spectra of Nanodisc incorporated CYP11A1
clearly define the active site hydrogen bonding, where the only change
being compared is a difference between a 3β-OH group vs a
corresponding ketone in natural CYP17A1 substrates. Significantly, this
single difference at a relatively remote site is sufficient to alter the Hbonding interactions with the critical Fe-O-O fragment in such a way as
to dictate its predisposition towards one of two alternative reaction
pathways. Though providing a structural explanation for the
differential reactivity of CYP17A1 substrates is itself a significant
contribution, the present results also convincingly illustrate the
impressive power of rR spectroscopy to identify localized structural
interactions that dictate reactivity patterns within the enzymatic cycles
of cytochromes P450 and related systems.
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Experimental Section
Full length human CYP17A1 was expressed from a synthetic
gene in DH5α co-transformed with the GroEL/ES chaperone system
(Takara Bio), purified to electrophoretic homogeneity and incorporated
into Nanodiscs as previously described [31–33] and are summarized in
details in Supporting Information. Resonance Raman spectra of frozen
samples were obtained using the 413.1 nm excitation line from a Kr+
laser, which effectively enhances heme modes and internal modes of
the Fe-O-O fragment (see Supporting Information for details). The
spectra were calibrated with fenchone (Sigma-Aldrich, WI) and
processed with Grams/32 AI software (Galactic Industries, Salem,
NH).

Supplementary Material
Supporting Information
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Figure S1.

The enzymatic cycle of cytochrome P450s. Note that the reaction

shown for 17-OH PROG also occurs for PROG and PREG.

Experimental Section
1. Protein preparation
1.1 Detailed Purification of CYP17A1
Frozen cell pellets, typically 25-30 g/L, from 6 L culture were
resuspended in 270mL Buffer A (0.1 M potassium phosphate pH 7.4,
0.05 M NaCl, 20% glycerol, 50 μM progesterone, 10 mM β-Me, 0.5 mM
PMSF, 0.1 mg/mL lysozyme, 0.1 mg/mL DNase, 0.1 mg/mL RNase).
Lysate was stirred at 4°C for 60 minutes. Resultant spheroplasts were
lysed by sonication using a Branson Sonifier 450 attached to a 0.5 cm
probe with six, two-minute cycles at 0.6 power and 70% duty cycle.
Lysate was centrifuged at 100,00 g for 30 minutes at 4°C. The
supernatant was discarded and membrane pellets resuspended in
270mL Buffer B (0.1 M potassium phosphate pH 7.4, 0.5 M NaCl, 20%
glycerol, 50 μM Progesterone, 10 mM β-Me, 0.5 mM PMSF) by stirring
for 1 hour at 4°C. To solubilize membrane associated proteins, 20%
Triton X-100 was added dropwise until the final detergent
concentration reached 1.5%. This solution was incubated at 4°C while
stirring for 1 hour, and was then centrifuged at 100,000 g for 30
minutes at 4°C. Supernatant containing solubilized membrane proteins
was collected and the insoluble membrane fraction discarded.
The solubilized fraction was immediately loaded onto a Ni-NTA
column equilibrated with 4 column volumes of Buffer B containing
1.5% Triton X-100 and washed with 5 column volumes of Buffer C
(0.05 M Tris, pH 7.4, 0.3 M NaCl, 20% glycerol, 50 μM progesterone,
0.02% Emulgen 913, 10 mM β-Me). Next, the column was washed
with 10 column volumes of Buffer C containing 50 mM imidazole, 5 mM
adenosine triphosphate, and 20 mM MgCl2. Bound protein was eluted
with 2 column volumes of Buffer C with 300mM imidazole and
collected in 4mL fractions. Colored fractions were pooled and dialyzed
once overnight against 1 L of 0.1 M potassium phosphate pH 7.4, 20%
glycerol, 0.05 M NaCl, 50 μM progesterone, 10 mM B-Me, and 2 mM
EDTA at 4°C in a 10,000 MWCO membrane, and twice against the
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same buffer without EDTA. Finally, protein was concentrated to ~50
μM, flash frozen in liquid N2, and stored at -80°C.
1.2 Nanodisc Incorporation of CYP17A1
In order to interrogate the membrane bound CYP17A1 enzyme
by rR without the deleterious effects of detergents, purified protein
was self-assembled into the lipid bilayer of Nanodiscs. These
nanoscale, discoidal, and monodisperse particles consist of a lipid
bilayer solubilized by an encircling amphipathic scaffold protein
(MSP1D1). Detailed protocols for the incorporation of a variety of
membrane proteins, including CYP17A1, into Nanodiscs have been
previously reported.[1]
Breifly, dried 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) was resuspended in 0.1 M potassium phosphate, pH 7.4 and
0.05 M NaCl. Triton X-100 was added in a 1.15:1 molar ratio of
detergent to lipid and complete solubilization of POPC was assisted by
30 minutes of sonication in a 60 °C water bath. Purified CYP17A1 and
His-tag cleaved MSP1D1 were added such that the final ratio of
CYP17A1:MSP1D1:POPC:Triton X-100 was 1:10:650:748. Following a
30 minute incubation on ice, self-assembly of Nanodics was initiated
by addition of 1 g Amberlite XAD-2 per milliliter of reconstitution
solution. After a 5 hour incubation at 4°C, Amberlite was removed by
filtration and Nanodiscs containing embedded CYP17A1 were isolated
on a Ni-NTA column. Properly formed discs were purified on a
Superdex 200 10/300 GL column (GE Life Sciences), and stored at 80°C until use in 0.1 M potassium phosphate buffer containing 15%
glycerol (v/v).
1.3 Preparation of samples for rR measurements
Samples for rR spectroscopy contained 100 μM
CYP17:Nanodiscs, 0.1 M potassium phosphate, pH 7.4, 0.25 M NaCl,
and 400 μM of progesterone or 17α-hydroxyprogesterone (Sigma).
Solutions were prepared in either distilled 30% (v/v) glycerol in H2O
or 30% (v/v) glycerol-d3 in D2O, and were de-aerated under argon for
5 minutes. Samples were reduced under anaerobic conditions with a
1.5 fold molar excess of sodium dithionite in the presence of 2.5 μM
methyl-viologen. Each sample reduced for 10 minutes at room
temperature and was transferred to a dry ice-ethanol bath held at -15
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°C where it was cooled for 1 minute. Oxy-ferrous complexes were
formed by bubbling 16O2 or 18O2 for 5 seconds, followed by rapid
freezing in liquid N2.

2. The rR measurements:
The resonance Raman spectra of oxy complexes of Nanodiscincorporated CYP17A1 were acquired using a Spex 1269 spectrometer
equipped with a Spec-10 LN-cooled detector having 2048 pixels
(Princeton Instruments, NJ). The data were measured with 413.1 nm
excitation line from a Kr+ laser (Coherent Innova Sabre Ion Laser) The
rR spectra were collected using back scattering (180°) geometry with
the laser beam being focused by a cylindrical lens to form a line image
on the sample. The laser power was adjusted to 1 mW or less. All
measurements were done at 77 K and total collection time was 4-5 hrs
in the high frequency region and 6-7 hrs in the low frequency region.
The slit width was set at 150 μm and the 1200 g/mm grating were
used; the linear reciprocal dispersion is 0.655 nm/mm near 400nm,
corresponding to 0.46 cm-1/pixel. The spectral resolution was
determined to be 4.1 cm-1. The frozen samples were contained in 5
mm O.D. NMR tubes (WG-5 ECONOMY, Wilmad). The NMR tubes were
positioned into a double-walled quartz low temperature cell filled with
liquid nitrogen. The sample tubes were spun to avoid local heating.
Spectra were calibrated with fenchone (Sigma-Aldrich, WI) and
processed with Grams/32 AI software (Galactic Industries, Salem,
NH).
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